A new trading day began on Monday, with Atea Pharmaceuticals Inc (NASDAQ: AVIR) stock price up 5.80% from the previous day of trading, before settling in for the closing price of $2.93. AVIR’s price has ranged from $2.75 to $4.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 104.50% over the past five years. Meanwhile, its annual earnings per share averaged -10.74%. With a float of $74.42 million, this company’s outstanding shares have now reached $84.46 million.
Let’s look at the performance matrix of the company that is accounted for 75 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atea Pharmaceuticals Inc (AVIR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atea Pharmaceuticals Inc is 12.32%, while institutional ownership is 65.83%. The most recent insider transaction that took place on Dec 10 ’24, was worth 1,023,475. In this transaction Director of this company sold 359,606 shares at a rate of $2.85, taking the stock ownership to the 451,897 shares. Before that another transaction happened on Dec 10 ’24, when Company’s Lead Independent Director proposed sale 359,606 for $2.85, making the entire transaction worth $1,023,475.
Atea Pharmaceuticals Inc (AVIR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -10.74% per share during the next fiscal year.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Trading Performance Indicators
Here are Atea Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 19.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.07, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Atea Pharmaceuticals Inc (AVIR)
Atea Pharmaceuticals Inc (NASDAQ: AVIR) saw its 5-day average volume 0.66 million, a positive change from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 31.99%. Additionally, its Average True Range was 0.17.
During the past 100 days, Atea Pharmaceuticals Inc’s (AVIR) raw stochastic average was set at 25.09%, which indicates a significant decrease from 44.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.58% in the past 14 days, which was higher than the 49.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.34, while its 200-day Moving Average is $3.61. Nevertheless, the first resistance level for the watch stands at $3.20 in the near term. At $3.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.35. If the price goes on to break the first support level at $3.05, it is likely to go to the next support level at $2.99. Assuming the price breaks the second support level, the third support level stands at $2.90.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Key Stats
With a market capitalization of 260.06 million, the company has a total of 84,463K Shares Outstanding. Currently, annual sales are 0 K while annual income is -135,960 K. The company’s previous quarter sales were 0 K while its latest quarter income was -31,150 K.
